Complementary exam for high-risk patients
One in five patients are at higher risk during colonoscopy due to bleeding risk, sedation risk, sedation-related cardiopulmonary events, or prior incomplete colonoscopy1,2,3. Currently about half of these patients with additional risks receive a non-colonoscopy exam. PillCam COLON offers a safer alternative, along with direct visualization for the detection of polyps, for patients with any of the following conditions:
- Severe pulmonary or cardiac disease
- Neurovascular disease
- Atrial fibrillation
- Valvular heart disease
- Mechanical valve
- Prior thromboembolic event
- Morbid obesity
- Chronic Obstructive Pulmonary Disease (COPD)
- Obstructive sleep apnea
- Liver disease
- Crohn's disease
- Ulcerative colitis
- Prior incomplete colonoscopy
- Allergic reaction to sedation
In addition, patients on anticoagulant or antiplatelet medications do not need to temporarily suspend or bridge their therapy when undergoing a PillCam COLON diagnostic procedure. This includes patients on the following medications:
- low-molecular weight heparin (e.g., enoxaparin, dalteparin)
- cyclooxygenase (COX) inhibitors
References 1 Rutter C. Adverse events after screening and follow-up colonoscopy. Cancer Causes Control (2012) 23:289-296.
2 Campbell E. Automated before-procedure electronic health record screening to assess appropriateness for GI endoscopy and sedation. Gastrointestinal Endoscopy 2012: In Press.
3 Given Imaging sponsored, multi-national survey of 303 GI physicians who estimated the percentage of large bowel examinations with patients having high bleed risk or high sedation risk.